# Evaluation of DEPREXIL in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment

> **NCT06496087** · NA · COMPLETED · sponsor: **Catalysis SL** · enrollment: 100 (actual)

## Conditions studied

- Depression
- Post-COVID-19 Syndrome
- Depression Mild
- Depression Moderate

## Interventions

- **DIETARY_SUPPLEMENT:** DEPREXIL

## Key facts

- **NCT ID:** NCT06496087
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496087, "Evaluation of DEPREXIL in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06496087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*